MSI colon cancers with epigenetic silencing of the MLH1 gene are correlated with the BRAF (V600E) mutation, while the KRAS hotspot mutation is greatly associated with MSS tumors and a subset of MSI tumors without defects in MLH1 or MSH2 genes [54]. The gene discussed is MSH2; the disease is malignant colon neoplasm.